|View printer-friendly version|
|April 17, 2001 11:27 a.m.|
|Teva Announces Final Approval of Famotidine 20 & 40mg|
WILL LAUNCH IMMEDIATELY
Jerusalem, Israel, April 17, 2001 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has awarded final approval for Famotidine 20mg and 40mg tablets, upon expiration of the patent on April 15, 2001. Teva USA will launch the products immediately.